1500000 IU Icikinase Recombinant Streptokinase Injection

Name: 1500000 IU Icikinase Recombinant Streptokinase Injection
Brand: Amari Trade Alliance LLP
Price: 835.36 INR
Availability: InStock

Price 835.36 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

1500000 IU Icikinase Recombinant Streptokinase Injection Specification

Indication
Acute STEMI, Thrombolysis

Life Span
See expiry on pack

Packaging Type
Vial

Origin of Medicine
India

Salt Composition
Streptokinase 1500000 IU

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
Icikinase

Drug Type
Prescription

Ingredients
Recombinant Streptokinase

Physical Form
Lyophilized Powder

Function
Thrombolytic Agent

Recommended For
Acute Myocardial Infarction

Dosage
1500000 IU per vial

Dosage Guidelines
IV infusion under medical supervision

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store at 2-8C

Strength
1500000 IU

Licensed In
India

Maximum Dose
As directed by physician

Route of Administration
IV infusion

Color
White powder

Made For
Hospital use

Preparation Time
Immediate before use

Side Effects
Nausea, hypotension

Diluent
Sterile water

Manufactured By
Icica Labs

1500000 IU Icikinase Recombinant Streptokinase Injection Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7-10 Days

About 1500000 IU Icikinase Recombinant Streptokinase Injection

Icikinase Recombinant Streptokinase Injection, acclaimed for its towering efficacy, is a prescription-only marvel designed for rapid thrombolysis in acute myocardial infarction (STEMI). Manufactured by Icica Labs, this lyophilized white powder (Strength: 1500000 IU) is suitable for adult patients. Its ephemeral preparation time ensures immediate readiness-just add sterile water and administer via IV infusion under medical supervision. Ace healthcare professionals prefer Icikinase for its precise dosage, consistent formulation, and reliable origin in India. Add to Cart now for hospital supply-maximize patient outcomes with a world-class, certified thrombolytic agent.

Comprehensive Clinical Use & Applications

The 1500000 IU Icikinase Recombinant Streptokinase Injection stands as a preferred choice for rapid thrombolytic therapy in acute STEMI and acute myocardial infarction. Application areas predominantly focus on critical hospital environments, where immediate IV infusion is administered by medical professionals. The product's ace method involves dissolving the lyophilized white powder in sterile water just before use, ensuring potency and efficacy. This marvel is tailored for adult patients in need of urgent myocardial intervention.

Sample Availability, Certifications & Logistics Support

Icikinase 1500000 IU Injection samples are available to verified medical institutions, highlighting certified quality and regulatory compliance. The supply ability aligns with large-scale hospital and institutional needs, ensuring reliable logistical support and seamless distribution. Sale price options and efficient exchange policies are coupled with streamlined transportation across India. All vials are properly packaged and certified, providing peace of mind in every transaction. Trust in ace logistics and robust certification for your essential thrombolytic requirements.

FAQ's of 1500000 IU Icikinase Recombinant Streptokinase Injection:

Q: How is Icikinase Recombinant Streptokinase Injection administered for acute STEMI?

A: This injection is prepared immediately before use by dissolving the lyophilized powder in sterile water. It is administered via intravenous infusion under strict medical supervision to ensure safe and effective thrombolytic action.

Q: What should I know about the usage guidelines and maximum dose for this medicine?

A: Dosage guidelines require 1500000 IU per vial, infused by IV as directed by a physician. The maximum dose is defined by the healthcare provider based on the patient's specific condition. Always follow medical supervision for administration.

Q: When can Icikinase Injection be used in clinical practice?

A: Icikinase is recommended for acute myocardial infarction (STEMI) cases where rapid thrombolysis is required. Initiation should occur in a hospital setting as soon as a diagnosis is confirmed and a physician has determined eligibility.

Q: Where is Icikinase Injection manufactured and licensed?

A: This acclaimed injection is manufactured by Icica Labs in India and is licensed for clinical use within India, aligning with stringent pharmaceutical standards and regulations for hospital environments.

Q: What are the possible side effects associated with Icikinase Injection?

A: Common side effects include nausea and hypotension. Healthcare professionals should monitor patients closely during and after infusion. Any unusual reactions should be reported to the supervising physician immediately.

Tell us about your requirement